Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 15 to 23 amino acid residues in defined sequence
Reexamination Certificate
2005-11-15
2005-11-15
Nickol, G. (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
15 to 23 amino acid residues in defined sequence
Reexamination Certificate
active
06965009
ABSTRACT:
In accordance with the present invention, we have discovered and purified a protein designated herein as p53as, which protein is present in normal cells of a mammal and is essentially identical to known normal growth controlling protein p53 of the same mammal, at least until the final 50 amino acids of the carboxy terminal end of the protein. The invention further includes an antibody specific for protein p53as, which antibody is designated herein as Ab p53as. The antibody may be either a monoclonal or polyclonal antibody and may be specific for p53as of any particular mammal such as mice ard humans.
REFERENCES:
patent: 4786718 (1988-11-01), Weinberg et al.
patent: A-O-529160 (1993-03-01), None
patent: PCT/US92/00878 (1992-01-01), None
patent: WO-A-9213970 (1992-08-01), None
Bowie et al (Science, 1990, 257:1306-1310).
Burgess et al (J of Cell Bio. 111:2129-2138, 1990).
Scott et al (Nature Genetics, 1999, 21:440-443).
Bork (Genome Research, 2000, 10:398-400).
Arai et al. Molecular and Cellular Biology Sep. 1986 p 3232 3239 vol. 6.
Kulesz-Martin, Molly F. et al. “Endogenous p53 Protein Generated from Wild-Type Alternatively Spliced p53 RNA in Mouse Epidermal Cells”, Mol. and Cell. Biol. Mar. 1994, p. 1698-1708.
Wu, Yu et al., “Activities and Response to DNA Damage of Latent and Active Sequence-Specific DNA Binding Forms of Mouse p53”, Proc. Natl. Acad. Sci., vol. 94, pp. 8982-8987, Aug. 1997.
Cruse et al., “Illustrated Dictionary of Immunology,” CRC Press, p. 280.
Kulesz-Martin, M. t al., “Endogenous Mouse p53 Protein Generated by Alternative Splicing,” J. Cellular Biochemistry Supplement, vol. 0, No. 18c, Feb. 13, 1994-Feb. 20, 1994, p. 170.
Wu, Y. et al., “Physiological Protein Varient of the Mouse p53 Tumor Suppressor Gene,” Proc. of the American Assoc. for Cancer Research, Annual Mtg., vol. 35, Apr. 10, 1994-Apr. 13, 1994, p. 605.
Bayle, J. et al., “The Carboxyl-Terminal Domain of the p53 Protein Regulates Sequence-Specific DNA Binding Through its Nonspecific Nucleic Acid Binding Activity,” Proc. Nat. Acad. Sciences of USA, vol. 92, No. 12, 1995, pp. 5729-5733.
Wu, Y. et al., “Wild-Type Alternatively Spliced p53: Binding to DNA and Interaction with the Major p53 Protein in Vitro and in Cells,” The EMBO Journal, vol. 13, No. 20, 1994, pp. 4823-4830.
Sevier et al., Clin. Chem, 27: pp. 1797-1806, 1981.
Gupta et al., PNAS USA, 90: pp. 2817-2821, 1993.
Arai, N. et al., “Immunology Distinct p53 Molecules Generated by Alternative Splicing,” Mol. and Cell. Biol., 6, 1986, pp. 3232-3239.
Balmain, A. et al., “Cloning and Characterization of the Abundant Cytoplasmic 7S RNA from Mouse Cells,” Nucleic Acids Res. 10, 1982, pp. 4259-4277.
Bargonetti, J. et al., “Site-Specific Binding of Wild-Type p53 to Cellular DNA is Inhibited by SV40 T Antigen and Mutant p53,” Genes & Dev. 6, 1992, pp. 1886-1898.
Bischoff, J.R. et al., “Human p53 Inhibits Growth inSchizosaccharomyces pombe,” Mol. and Cell. Biol. 12, 1992, pp. 1405-1411.
Burns, P.A. et al., “Loss of Heterozygosity and Mutational Alterations of the p53 Gene in Skin Tumors of Interspecific Hybrid Mice,” Oncogene 6, 1991, pp. 2363-2369.
Crook, T. et al., “Modulation of Immortalizing Properties of Human Papillomavirus Type 16E7 by p53 Expression,” J. Virol. 6, 1991, pp. 505-510.
Davies, R. et al., “Antioxidants Can Delay Liver Cell Maturation Which in Turn Affects γ-Glutamyltranspeptidase Expression,” Carcinogen. 14, 1993, pp. 47-52.
Eliyahu, D. et al., “Meth A Fibrosarcoma Cells Express Two Transforming Mutant p53 Species,” Oncogene 3, 1988, pp. 313-321.
Farmer, G. et al., “Wild-Type p53 Activates Transcription in vitro,” Nature 358, 1992, pp. 83-86.
Finlay, C.A. et al., “The p53 Proto-Oncogene Can Act as a Supressor of Transformation,” Cell 57, 1989, pp. 1083-1093.
Fontoura, B.M.A. et al., “p53 is Covalently Linked to 5.8S rRNA,” Mol. Cell. Biol. 12, 1992, pp. 5145-5151.
Foord, O.S. et al., “A DNA Binding Domain is Contained in the C-Terminus of Wild Type p53 Protein,” Nucleic Acids Res. 19, 1991, pp. 5191-5198.
Foulkes, N.S. et al., “More is Better: Activators and Repressors from the Same Gene,” Cell 68, 1992, pp. 411-414.
Hainaut, P. et al., “Interaction of Heat-Shock Protein 70 with p53 Translated in vitro Evidence for Interaction with Dimeric p53 and for a Role in the Regulation of p53 Conformation,” EMBO J. 11, 1992, pp. 3513-3520.
Han, K. et al., “Altered Levels of Endogenous Retrovirus-Like Sequence (VL30) RNA During Mouse Epidermal Cell Carcinogenesis,” Mol. Carcinogenesis 3, 1990, pp. 75-82.
Han, K. et al., “Altered Expression of Wild-Type 53 Tumor Supressor Gene During Murine Epithelial Cell Transformation,” Cancer Research 52, 1992, pp. 749-753.
Han, K. et al., “Alternatively Spliced p53 RNA in Transformed and Normal Cells of Different Tissue Types,” Nucleic Acids Res. 20(8), 1992, pp. 1979-1981.
Hupp, T.R. et al., “Regulation of the Specific DNA Binding Function of p53,” Cell 71, 1992, pp. 875-886.
Jenkins, J.R. et al., “Cellular Immortalization by cDNA Clone Encoding the Transformation-Associated Phosphoprotein p53,” Nucleic Acids Res. 12, 1984, pp. 5609-5626.
Kastan, M.B. et al., “Participation of p53 Protein in the Cellular Response to DNA Damage,” Cancer Research 51, 1991, pp. 6304-6311.
Kastan, M.B. et al., “A Mammalian Cell cycle Checkpoint Pathway Utilizing p53 and GADD45 is Defective in Ataxia-Telangiectasia,” Cell 71, 1992, pp. 587-597.
Kulesz-Martin, M. et al., “Mouse Cell Clones for Improved Quantitation of Carcinogen-Induced Altered Differentiation,” Carcinogenisis 6, 1985, pp. 1245-1254.
Kulesz-Martin, M. et al., “Retinoic Acid Enhancement of an Early Step in the Transformation of Mouse Epidermal Cells in vitro,” Carcinogenesis 7, 1986, pp. 1425-1429.
Kulesz-Martin, M. et al., “Pemphigoid, Pemphigus and Desmoplakin as Antigenic Markers of Differentiation in Normal and Tumorigenic Mouse Keratinocyte Lines,” Cell Tissue Kinet. 22, 1989, pp. 279-290.
Kulesz-Martin, M. et al., “Tumor Progression of Murine Epidermal Cells After Treatment In vitro with 12-0-Tetradecanoylphorbol-13-Acetate or Retinoic Acid,” Cancer Research 51, 1991, pp. 4701-4706.
Kulesz-Martin, M. et al. “Properties of Carcinogen Altered Mouse Epidermal Cells Resistant to Calcium-Induced Terminal Differentiation,” Carcinogen 4, 1983, pp. 1367-1377.
Lane, D.P., “p53, Guardian of the Genome,” Nature 358, 1992, pp. 15-16.
Milne, D.M. et al., “Mutation of the Casein Kinase II Phosphorylation Site Abolishes the Anti-Proliferative Activity of p53,” Nucleic Acids Res. 20, 1992, pp. 5565-5570.
Milner, J., “The Role of p53 in the Normal Control of Cell Proliferation,” Current Opinion in Cell Biology 3, 1991, pp. 282-286.
Milner, J., “Different Forms of p53 Detected by Monoclonal Antibodies in Non-Dividing and Dividing Lymphocytes,” Nature 20, 1984, pp. 143-145.
Milner, J. et al., “Cotranslation of Activated Mutant p53 with Wilde Type Drives the Wild-Type p53 Protein into the Mutant Conformation,” Cell 65, 1991, pp. 765-774.
Momand, J. et al., “The mdm-2 Oncogene Product Forms a Complex With the p53 Protein and Inhibits p53-Mediated Transactivation,” Cell 69, 1992, pp. 1237-1245.
Nigro, J.M. et al., “Human p53 and CDC2Hs Genes Combine to Inhibit the Proliferation ofSaccharomyces cerevisiae,” Mol. and Cell Biol. 12, 1992, pp. 1357-1365.
Oren, M. et al., “Molecular Cloning of cDNA Specific for the Murine p53 Cellular Tumor Antigen,” Proc. Natl. Acad. Sci. USA, 80, 1983, pp. 56-59.
Prives, C. et al., “The p53 Tumor Suppressor Protein: Meeting Review,” Genes & Dev. 7, 1993,
Dunn Michael L.
Health Research , Inc.
Nickol G.
Yaen C.
LandOfFree
p53 as protein and antibody therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with p53 as protein and antibody therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and p53 as protein and antibody therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3522035